SCHEMBL26134176

SCHEMBL26134176

Cn1nccc1-c1c(C2=CCC3(CCNCC3)CC2)n(C)c2ncnc(N)c12

nearest known ligand 0.32

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ LRRK2 Q5S007 1/20 0.32
▸ RET P07949 1/20 0.31
▸ PRMT5 O14744 2/20 0.30
▸ METTL3 Q86U44 2/20 0.30
▸ CCNT1 O60563 1/20 0.30
▸ CDK9 P50750 1/20 0.30
▸ PIK3CD O00329 1/20 0.30
▸ ABL1 P00519 1/20 0.30
▸ EGFR P00533 1/20 0.30
▸ HCK P08631 1/20 0.30
▸ SRC P12931 1/20 0.30
▸ KDR P35968 1/20 0.30
▸ PIK3CA P42336 1/20 0.30
▸ PIK3CB P42338 1/20 0.30
▸ MTOR P42345 1/20 0.30
▸ PIK3CG P48736 1/20 0.30
▸ EPHB4 P54760 1/20 0.30
▸ PRKDC P78527 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26107963 0.84 LRRK2 (0.34) LRRK2RETCCNT1CDK9
SCHEMBL30582531 0.83 JAK2 (0.37) —
SCHEMBL26134716 0.83 JAK2 (0.37) —
SCHEMBL26133885 0.82 RET (0.35) LRRK2RETPRMT5METTL3PIK3CD
SCHEMBL30582605 0.82 CCNT1 (0.38) LRRK2RETCCNT1CDK9PIK3CD
SCHEMBL26106044 0.82 CCNT1 (0.38) LRRK2RETCCNT1CDK9PIK3CD
SCHEMBL26134467 0.82 SRC (0.38) RETABL1EGFRSRCKDR
SCHEMBL30582606 0.82 SRC (0.38) RETABL1EGFRSRCKDR
SCHEMBL30582601 0.81 PIK3CD (0.40) LRRK2RETCCNT1CDK9PIK3CD
SCHEMBL26105782 0.81 PIK3CD (0.40) LRRK2RETCCNT1CDK9PIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4499616-A1 SPIROBICYCLIC COMPOUNDS Acerand Therapeutics (Hong Kong) Limited (HK) 2025-02-05 — — EP disclosed
CN-119013260-A Spirobicyclic compounds 优领医药科技(香港)有限公司 2024-11-22 — — CN disclosed
WO-2023192502-A1 SPIROBICYCLIC COMPOUNDS ACERAND THERAPEUTICS (USA) LIMITED (US) 2023-10-05 — — WO disclosed
Send feedback